3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lung Neoplasms
20
Breast Neoplasms
9
Prostatic Neoplasms
6
Stomach Neoplasms
5
Carcinoma, Hepatocellular
5
Melanoma
4
Colorectal Neoplasms
4
Multiple Pulmonary Nodules
3
Head and Neck Neoplasms
3
Disease
3
Carcinoma, Non-Small-Cell Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Smoking Cessation
2
Smoking
2
Sarcopenia
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neuroendocrine Tumors
2
Neoplasms
2
Liver Cirrhosis
2
Gastrointestinal Neoplasms
2
Anastomotic Leak
2
Vasculitis
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Tobacco Use Cessation
1
Tobacco Smoking
1
Testicular Neoplasms
1
Solitary Pulmonary Nodule
1
Interventions
Cyclophosphamide
30
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
21
Prednisone
20
Etoposide
20
Vincristine
16
Whole-Body Irradiation
15
Doxorubicin
15
fludarabine phosphate
14
Peripheral Blood Stem Cell Transplantation
14
romidepsin
13
Mycophenolic Acid
12
Lenalidomide
12
Gemcitabine
12
Cyclosporine
10
Azacitidine
10
Brentuximab Vedotin
9
Bortezomib
9
Alemtuzumab
8
Dexamethasone
7
Methotrexate
6
Cytarabine
6
Busulfan
6
Carmustine
5
pembrolizumab
4
fludarabine
4
Vorinostat
4
Tacrolimus
4
Rituximab
4
Melphalan
4
Ifosfamide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, T-Cell, Peripheral
×
Tomography, X-Ray Computed
×
Clear all
NCT06362148
2026-05-01
CIRCULATE
University of Aarhus
Active not recruiting
50 enrolled